Technology Networks
| ||
| Permissions | ||
|
Permission to use, copy and distribute documents presented on this World Wide Web site and related graphics is not granted without prior written permission of Technology Networks Ltd
To obtain this permission contact:
In cases where permission is granted, it is done so under the provision that the above copyright notice and this permission notice appear in all copies. All other rights are reserved. |
Good News for Nanomedicine
Quantum dots appear safe in pioneering study on primates. NIH Study Finds that Coffee Drinkers have Lower Risk of Death Older adults who drank coffee — caffeinated or decaffeinated — had a lower risk of death overall than others who did not drink coffee. Finnish Researchers Discover Genes Inhibiting the Spread of Prostate Cancer Researchers utilize the cell spot micro array technology to study the impacts of all genes in an entire genome in a single experiment. Stabilizing Fanconi Anemia with Antioxidants Fanconi anemia (FA) is a rare genetic disorder which affects one person in 350,000. Genetic Predictor of Breast Cancer Response to Chemotherapy Gene expression 'signatures' to measure the susceptibility of tumor cells to chemotherapy. Revolutionary New Cancer Targeting Technology Described in Nature Medicine Immunocore scientists manage to overcome cancer problem by boosting the ability of cancer-specific TCRs. New Biomarkers Could Offer Vital Clues for Cancer Research European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore. Idera Pharmaceuticals Announces Top-line Results from Phase 2 Clinical Trial IMO-2055 to be used in treatment of patients with advanced head and neck cancer. Next-Generation “Epigenetic” Cancer Pill Shown to be Safe Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to a Phase I trial reported today in Clinical Cancer Research. Study Points to Potential New Treatment for Deadly Pancreatic Cancer Cancer Research UK-funded scientists have shown how a promising new class of drugs might be used to treat aggressive forms of pancreatic cancer, according to a study published in Nature. 
| |
